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eLeft ventricular assist device (LVAD) support has
offered many individuals with end-stage heart failure
an improved quality of life and enhanced survival.
Prolonged mechanical assistance, however, has
shown the potential to induce hemodynamic and
structural changes in the native heart. One such
dismal drawback is the development of de novo aortic
valve lesions leading to aortic insufficiency (AI).
Significant AI can lead to ineffective LVAD output
and end-organ malperfusion, and may hamper the
success of recovery attempts. If AI at the time of
LVAD implantation can be proactively managed by
replacement or closure of the aortic valve, later
development of aortic valve dysfunction may pose a
difficult management issue.
A 53-year-old male patient (height, 190 cm;
weight, 90 kg) with end-stage dilated cardiomyop-
athy was uneventfully implanted with a Thoratec
HeartMate II LVAD (Thoratec Corporation, Pleas-
anton, California) intended as a bridge to transplan-
tation. Ten months postoperatively, he showed
progressively worsening AI requiring hospital read-
missions for increased exercise intolerance, desatura-
tion, and arrhythmias. In view of the unfavorable
anthropometric characteristics, any attempt to antic-
ipate transplantation was unsuccessful for lack of
appropriate donors. Ineffective LVAD output, pul-
monary edema with desaturation, and arrhythmias
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October 7, 2011, accepted October 14, 2011.ultimately required endotracheal intubation and car-
diopulmonary resuscitation. Since neither optimal
medical therapy nor LVAD adjustments provided
hemodynamic stability, the heart team decided for
emergency life-saving aortic valve implantation
(Fig. 1, Online Video 1). Transcatheter aortic valve
mplantation was undertaken with a percutaneous
pproach through the right femoral artery. Through
n 18-F introducer, an extra-stiff guidewire was
ositioned in the left ventricle, and a 29-mm Cor-
Valve (Medtronic, Milwaukee, Wisconsin) was
mplanted under fluoroscopy and echo control.
ue to a moderate periprosthetic regurgitation
Fig. 2, Online Video 2), a second 29-mm Cor-
Valve was deployed within the previous valve prosthesis
Figure 1. Fluoroscopic View Showing Severe Aortic Valve
Regurgitation Along With the HeartMate II DeviceAlso see Online Video 1.
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115(Fig. 3), with minimal residual leak (Fig. 4, Online Video 3), and
no complications. The femoral access was repaired by the
Prostar XL Closure device (Abbott Vascular, Santa Clara,
California). The patient’s hemodynamics improved imme-
diately and led to a successful extubation by postoperative
Figure 2. Fluoroscopic View Showing Moderate Periprosthetic Aortic
Valve Regurgitation
See also Online Video 2.
Figure 3. Fluoroscopic View Showing Second 29-mm CoreValve
Deployment Within the Previous Valve ProsthesisDay 1. At the time of discharge, echocardiography displayed
very little residual regurgitation. The patient is currently in
New York Heart Association functional class II, waiting for
heart transplantation.
De novo AI tends to develop and progress with the
duration of LVAD support, has a multifactorial etiology,
and can lead to ineffective LVAD output and end-organ
malperfusion. In our case, transfemoral transcatheter Cor-
eValve implantation resulted in a life-saving reproducible
procedure to manage an acutely occurred hemodynamic
instability. A longer follow-up and further experience are
needed to find out the durability of this combination
therapy.
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APPENDIX
Figure 4. Fluoroscopic View Showing Reduced Periprosthetic Aortic
Valve Regurgitation
See also Online Video 3.For accompanying videos, please see the online version of this article.
